Three-Year Follow-Up Detecting Choroidal Neovascularization with Swept Source Optical Coherence Tomography Angiography (SS-OCTA) after Successful Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Patients
2.2. Half-Fluence Photodynamic Therapy
2.3. Image Acquisition
2.4. Data Collected
2.5. Statistical Analyses
3. Results
4. Discussion
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- van Rijssen, T.J.; van Dijk, E.H.; Yzer, S.; Ohno-Matsui, K.; Keunen, J.E.; Schlingemann, R.O.; Sivaprasad, S.; Querques, G.; Downes, S.M.; Fauser, S.; et al. Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog. Retin. Eye Res. 2019, 73, 100770. [Google Scholar] [CrossRef] [PubMed]
- Nicolò, M.; Desideri, L.F.; Vagge, A.; Traverso, C.E. Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review. Pharmaceuticals 2020, 13, 264. [Google Scholar] [CrossRef]
- Iacono, P.; Da Pozzo, S.; Varano, M.; Parravano, M. Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy. Pharmaceuticals 2020, 13, 349. [Google Scholar] [CrossRef] [PubMed]
- Dansingani, K.K.; Balaratnasingam, C.; Klufas, M.A.; Sarraf, D.; Freund, K.B. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am. J. Ophthalmol. 2015, 160, 1243–1254. [Google Scholar] [CrossRef] [PubMed]
- Quaranta-El Maftouhi, M.; El Maftouhi, A.; Eandi, C.M. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am. J. Ophthalmol. 2015, 160, 581–587. [Google Scholar] [CrossRef] [PubMed]
- de Carlo, T.E.; Rosenblatt, A.; Goldstein, M.; Baumal, C.R.; Loewenstein, A.; Duker, J.S. Vascularization of irregular retinal pigment epithelial detachments in chronic central serous chorioretinopathy evaluated with OCT angiography. Ophthalmic Surg. Lasers Imaging Retin. 2016, 47, 128–133. [Google Scholar] [CrossRef] [PubMed]
- Bousquet, E.; Bonnin, S.; Mrejen, S.; Krivosic, V.; Tadayoni, R.; Gaudric, A. Optical coherence tomography angiography of flat irregular pigment epithelium detachment in chronic central serous chorioretinopathy. Retina 2018, 38, 629–638. [Google Scholar] [CrossRef]
- Guo, J.; Tang, W.; Liu, W.; Chang, Q.; Xu, G. Clinical features of flat irregular pigment epithelial detachment associated with choroidal neovascularization in chronic central serous chorioretinopathy. Retina 2020, 41, 199–207. [Google Scholar] [CrossRef]
- Savastano, M.C.; Rispoli, M.; Lumbroso, B. The incidence of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography. Retina 2020, 41, 302–308. [Google Scholar] [CrossRef]
- Hage, R.; Mrejen, S.; Krivosic, V.; Quentel, G.; Tadayoni, R.; Gaudric, A. Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization. Am. J. Ophthalmol. 2015, 159, 890–903. [Google Scholar] [CrossRef]
- Sulzbacher, F.; Schütze, C.; Burgmüller, M.; Vécsei-Marlovits, P.V.; Weingessel, B. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA). Graefe’s Arch. Clin. Exp. Ophthalmol. 2019, 257, 1581–1590. [Google Scholar] [CrossRef] [PubMed]
- Su, Y.; Zhang, X.; Gan, Y.; Ji, Y.; Wen, F. Characteristics and Associated Factors of Flat Irregular Pigment Epithelial Detachment with Choroidal Neovascularization in Chronic Central Serous Chorioretinopathy. Front. Med. 2021, 8, 687023. [Google Scholar] [CrossRef] [PubMed]
- Bonini Filho, M.A.; de Carlo, T.E.; Ferrara, D.; Adhi, M.; Baumal, C.R.; Witkin, A.J.; Reichel, E.; Duker, J.S.; Waheed, N.K. Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography. JAMA Ophthalmol. 2015, 133, 899–906. [Google Scholar] [CrossRef] [PubMed]
- Costanzo, E.; Cohen, S.Y.; Miere, A.; Querques, G.; Capuano, V.; Semoun, O.; El Ameen, A.; Oubraham, H.; Souied, E.H. Optical coherence tomography angiography in central serous chorioretinopathy. J. Ophthalmol. 2015, 2015, 134783. [Google Scholar] [CrossRef] [PubMed]
- Fung, A.T.; Yannuzzi, L.A.; Freund, K.B. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina 2012, 32, 1829–1837. [Google Scholar] [CrossRef] [PubMed]
- Lee, G.-I.; Kim, A.Y.; Kang, S.W.; Cho, S.C.; Park, K.H.; Kim, S.J.; Kim, K.T. Risk Factors and Outcomes of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy. Sci. Rep. 2019, 9, 3927. [Google Scholar] [CrossRef] [PubMed]
- Erikitola, O.C.; Crosby-Nwaobi, R.; Lotery, A.J.; Sivaprasad, S. Photodynamic therapy for central serous chorioretinopathy. Eye 2014, 28, 944–957. [Google Scholar] [CrossRef]
- Chen, Y.C.; Chen, S.N. Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy. Br. J. Ophthalmol. 2020, 104, 1561–1566. [Google Scholar] [CrossRef]
- Guo, J.; Tang, W.; Xu, S.; Liu, W.; Xu, G. OCTA evaluation of treatment-naïve flat irregular PED (FIPED)-associated CNV in chronic central serous chorioretinopathy before after half-dose, P.D.T. Eye 2021, 35, 2871–2878. [Google Scholar] [CrossRef]
- Loo, R.H.; Scott, I.U.; Flynn, H.W.; Gass, J.D.M.; Murray, T.G.; Lewis, M.L.; Rosenfeld, P.J.; Smiddy, W.E. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002, 22, 19–24. [Google Scholar] [CrossRef]
- Mrejen, S.; Balaratnasingam, C.; Kaden, T.R.; Bottini, A.; Dansingani, K.; Bhavsar, K.V.; Yannuzzi, N.A.; Patel, S.; Chen, K.C.; Yu, S.; et al. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology 2019, 126, 576–588. [Google Scholar] [CrossRef] [PubMed]
- Shiragami, C.; Takasago, Y.; Osaka, R.; Kobayashi, M.; Ono, A.; Yamashita, A.; Hirooka, K. Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization. Am. J. Ophthalmol. 2018, 193, 80–86. [Google Scholar] [CrossRef]
- Kim, R.Y.; Ma, G.J.; Park, W.K.; Kim, M.; Park, Y.G.; Park, Y.H. Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy. Medicine 2021, 100, e26980. [Google Scholar] [CrossRef] [PubMed]
- Pang, C.E.; Freund, K.B. Pachychoroid neovasculopathy. Retina 2015, 35, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Ueta, T.; Obata, R.; Inoue, Y.; Iriyama, A.; Takahashi, H.; Yamaguchi, T.; Tamaki, Y.; Yanagi, Y. Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009, 116, 2400–2406. [Google Scholar] [CrossRef] [PubMed]
- Querques, G.; Srour, M.; Massamba, N.; Georges, A.; Moussa, N.B.; Rafaeli, O.; Souied, E.H. Functional characterization and multimodal imaging of treatment-naive “quiescent” choroidal neovascularization. Investig. Ophthalmol. Vis Sci. 2013, 54, 6886–6892. [Google Scholar] [CrossRef] [PubMed]
- Sacconi, R.; Tomasso, L.; Corbelli, E.; Carnevali, A.; Querques, L.; Casati, S.; Bandello, F.; Querques, G. Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: A OCT-angiography study. Eye 2019, 33, 1809–1817. [Google Scholar] [CrossRef] [PubMed]
- Montero, J.A.; Ruiz-Moreno, J.M.; Fernandez-Munoz, M. Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy. Eur. J. Ophthalmol. 2011, 21, 503–505. [Google Scholar] [CrossRef]
- Chan, W.-M.; Lam, D.S.C.; Lai, T.Y.Y.; Tam, B.S.M.; Liu, D.T.L.; Chan, C.K.M. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br. J. Ophthalmol. 2003, 87, 1453–1458. [Google Scholar] [CrossRef]
- Türkçüoğlu, P.; İlhan, N.; Kurt, J.; Aydemir, O.; Çeliker, Ü. The protective role of Visudyne eyeglass against VEGF synthesis after photodynamic therapy with verteporfin. Acta. Ophthalmol. 2009, 87, 871–874. [Google Scholar]
- Daruich, A.; Matet, A.; Dirani, A.; Bousquet, E.; Zhao, M.; Farman, N.; Jaisser, F.; Behar-Cohen, F. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog. Retin Eye Res. 2015, 4, 82–118. [Google Scholar] [CrossRef] [PubMed]
- Song, I.S.; Shin, Y.U.; Lee, B.R. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography. Am. J. Ophthalmol. 2012, 154, 366–375.e4. [Google Scholar] [CrossRef]
- Faghihi, H.; Mahmoudi, A.; Pour, E.K.; Ebrahimiadib, N.; Fadakar, K.; Ghassemi, F.; Mirshahi, A.; Khodabande, A.; Khojasteh, H.; Bazvand, F.; et al. Choroidal features in flat irregular pigment epithelial detachment associated with Chronic central serous chorioretinopathy: Avascular versus vascularized. PLoS ONE. 2021, 16, e0257763. [Google Scholar] [CrossRef] [PubMed]
- Li, X.Q.; Larsen, M.; Munch, I.C. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students. Investig. Ophthalmol. Vis. Sci. 2011, 52, 8438–8441. [Google Scholar] [CrossRef]
- Kim, R.Y.; Chung, D.H.; Kim, M.; Park, Y.H. Use of choroidal vascularity index for choroidal structural evaluation in central serous chorioretinopathy with choroidal neovascularization. Retina 2019, 40, 1395–1402. [Google Scholar] [CrossRef] [PubMed]
- Wu, J.-S.; Chen, S.-N. Optical Coherence Tomography Angiography for Diagnosis of Choroidal Neovascularization in Chronic Central Serous Chorioretinopathy after Photodynamic Therapy. Nature 2019, 9, 9040. [Google Scholar] [CrossRef] [PubMed]
- Yeo, J.H.; Oh, R.; Kim, Y.J.; Kim, J.G.; Yoon, Y.H.; Lee, J.Y. Choroidal neovascularization secondary to central serous chorioretinopathy: OCT angiography findings and risk factors. J. Ophthalmol. 2020, 2020, 7217906. [Google Scholar] [CrossRef] [PubMed]
- Spaide, R.F.; Campeas, L.; Haas, A.; Yannuzzi, L.A.; Fisher, Y.L.; Guyer, D.R.; Slakter, J.S.; Sorenson, J.A.; Orlock, D.A. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996, 103, 2070–2079. [Google Scholar] [CrossRef]
Diagnosis | CNV CSC (N = 5) | Non-CNV CSC (N = 19) | p 1 |
---|---|---|---|
Age, years | 51.6 (3.4) [47.3; 55.9] | 46.3 (9.8) [41.6; 51.0] | 0.044 * |
51.0 (7) | 45.0 (10) | ||
Duration of symptoms, months. | 21.6 (28.3) [−13.6; 56.8] | 22.2 (12.5) [16.2; 28.2] | 0.406 |
12.0 (36) | 24.0 (24) | ||
CNV CSC, N (%) | Non-CNV CSC, N (%) | ||
FA | p 2 | ||
Hyperfluorescence leakage | 3 (60.0%) | 7 (36.8%) | 0.616 |
Diffuse oozing | 2 (40.0%) | 7 (36.8%) | 1.00 |
Both | 0 (0.0%) | 5 (26.3%) | 0.544 |
FIPED | p 2 | ||
Presence | 4 (80.0%) | 14 (73.3%) | 0.399 |
Absence | 1 (20.0%) | 5 (26.3%) | 0.455 |
BCVA | CNV CSC (N = 5) | Non-CNV CSC (N = 19) | p 1 |
---|---|---|---|
12-month visit | 0.67 (0.22) [0.37; 0.96] | 0.77 (0.27) [0.63–0.9] | 0.367 |
0.63 (0.45) | 0.8 (0.37) | ||
24-month visit | 0.63 (0.26) [0.37; 0.96] | 0.80 (0.29) [0.66; 0.93] | 0.297 |
0.63 (0.45) | 0.80 (0.20) | ||
36-month visit | 0.56 (0.14) [0.37; 0.96] | 0.75 (0.27) [0.61–0.87] | 0.446 |
0.63 (0.45) | 0.8 (0.37) | ||
p 2 | 0.368 | 0.174 |
CNV CSC (N = 5) | Non-CNV CSC (N = 19) | p 1 | |
---|---|---|---|
CFT | |||
12-month visit | 219.5 (56.9) [128.9; 310.1] | 303.4 (56.0) [277.2; 329.6] | 0.018 * |
207.0 (107) | 300.5 (104) | ||
24-month visit | 219.5 (51.3) [137.8; 301.2] | 297.2 (73.5) [262.7; 331.6] | 0.046 * |
208.0 (96) | 279.0 (122) | ||
36-month visit | 230.6 (49.2) [169.6; 291.6] | 297.8 (69.2) [264.4; 331.1] | 0.043 * |
229.0 (97) | 308.0 (128) | ||
p 2 | 0.801 | 0.986 | |
CRT | |||
12-month visit | 205.0 (12.1) [185.7; 224.3] | 235.2 (74.0) [200.5; 269.8] | 0.309 |
206.5 (23) | 217.0 (40) | ||
2-month visit | 211.0 (15.4) [186.5; 235.5] | 225.5 (56.6) [199.0; 252.0] | 0.794 |
218.0 (25) | 217.0 (46) | ||
36-month visit | 211.2 (18.1) [188.7; 233.7] | 214.9 (44.4) [193.5; 236.4] | 0.836 |
217.0 (33) | 218.0 (32) | ||
p 2 | 0.805 | 0.666 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Esteban-Floría, O.; Pérez-Rivasés, G.; Honrubia-Grijalbo, A.; Bartolomé-Sesé, I.; Díaz-Barreda, M.D.; Boned-Murillo, A.; Cisneros-Arias, P.; Mateo-Gabás, J.; Ascaso-Puyelo, F.-J. Three-Year Follow-Up Detecting Choroidal Neovascularization with Swept Source Optical Coherence Tomography Angiography (SS-OCTA) after Successful Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Diagnostics 2023, 13, 2792. https://doi.org/10.3390/diagnostics13172792
Esteban-Floría O, Pérez-Rivasés G, Honrubia-Grijalbo A, Bartolomé-Sesé I, Díaz-Barreda MD, Boned-Murillo A, Cisneros-Arias P, Mateo-Gabás J, Ascaso-Puyelo F-J. Three-Year Follow-Up Detecting Choroidal Neovascularization with Swept Source Optical Coherence Tomography Angiography (SS-OCTA) after Successful Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Diagnostics. 2023; 13(17):2792. https://doi.org/10.3390/diagnostics13172792
Chicago/Turabian StyleEsteban-Floría, Olivia, Guillermo Pérez-Rivasés, Ana Honrubia-Grijalbo, Isabel Bartolomé-Sesé, María Dolores Díaz-Barreda, Ana Boned-Murillo, Pablo Cisneros-Arias, Javier Mateo-Gabás, and Francisco-Javier Ascaso-Puyelo. 2023. "Three-Year Follow-Up Detecting Choroidal Neovascularization with Swept Source Optical Coherence Tomography Angiography (SS-OCTA) after Successful Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy" Diagnostics 13, no. 17: 2792. https://doi.org/10.3390/diagnostics13172792